Navigation Links
Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations
Date:10/28/2010


.33Shares used to compute net (loss) income per share (1):Basic58,13856,04557,47355,787Diluted66,61257,36866,21657,135(1) The company adopted the two-class method in calculating net income per share on a GAAP basis, which excludes the weighted average unvested restricted stock awards outstanding of 323,582 and 638,105 for thethree months ended October 2, 2010 and October 3, 2009, respectively, and 386,808 and 724,469 for the nine monthsended October 2, 2010 and October 3, 2010, respectively.The following table reconciles the specific items excluded from GAAP net income from continuing operations in the calculation of non-GAAP net income from continuing operations and diluted net income per share from continuing operations for the periods shown below:

THORATEC CORPORATION
Reconciliation of GAAP to Non-GAAP Net Income from Continuing Operations
(Unaudited)
(in thousands, except for per share data) Three Months Ended Nine Months Ended Net income reconciliationOctober 2,
2010October 3,
2009October 2,
2010October 3,
2009Net income from continuing operations on a GAAP basis$
5,480$
,776$
46,381$
20,832Share-based compensation expense:- Cost of product sales322234947789- Selling, general and administrative1,8581,6096,0745,153- Research and development7915942,6021,992Amortization of purchased intangibles2,4462,3597,3267,441HeartWare transaction costs-984-12,314Impact of ASC 470-202,1291,9456,1685,659Unrealized gain on embedded derivative
instrument on HeartWare loan-(5,240)-(5,240)Income tax effect of non-GAAP income
before tax607(158)434(1,801)Income tax effect of non-GAAP
adjustments(2,820)(832)(8,236)(8,785)Net income from continuing operations on a non-GAAP basis$
20,813$
3,271$
,696$
38,354 Three Months Ended Nine Months Ended Diluted net income from continuing operations per share reconciliationOctober 2,
2010October 3,
2009October 2,
2010October 3,
2009Di
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
(Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 8, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Product Development of BioMarin, will present a company update at ... June 15, 2011 at 10:00 a.m. CT.   ... conference call via the investor section of the BioMarin website, ...
... About 20,000 children in the United States under the ... For many, the disease goes beyond painful red, dry ... equally life altering—with nearly 50 percent of children reporting ...  The XTRAC® Excimer Laser ( www.XTRACLaser.com ) offers new hope ...
Cached Medicine Technology:BioMarin to Present at the William Blair Growth Stock Conference 2XTRAC Laser Provides New Hope for Children with Psoriasis 2XTRAC Laser Provides New Hope for Children with Psoriasis 3
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses and ... collection of wedding dresses , and launches a site-wide women’s ... dress on your big day; the wedding gown is the ... to find the most suitable wedding dress. Now, we are ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... New evidence suggests screening for colorectal cancer, which is ... people, should start five to 10 years earlier for ... a University of Rochester Medical Center study said. , ... were diagnosed with colon cancer approximately seven years earlier ...
... ATLANTA, Feb. 13 Vendormate, Inc. announced ... America (CHCA) to make,Vendormate VISION(TM), its vendor ... children,s hospitals. Vendormate VISION(TM) is,used by leading ... better manage,the increasingly complex requirements of government-mandated ...
... at The Wistar Institute have collaborated on a major advance ... the deadliest cancers in humans. The culmination of 10 years ... new cancer therapies. , During much of its lifetime, ... in an inactive form, stored inside densely knotted structures in ...
... TRIANGLE PARK, N.C., Feb. 13 Quintiles,Transnational Corp. ... been certified by the College of American Pathologists ... supporting clinical trials in the first,quarter of 2007. ... been adding,services and analytical capabilities to a growing ...
... Corporation,(NYSE: SYK ) today announced that its Board ... $750 million of its common stock. Purchases may,be made ... privately negotiated,transactions or otherwise. The manner, timing and amount ... based on their evaluation of,market conditions, stock price and ...
... results further convinces Accipiter ... NEW YORK, Feb. 13 Accipiter Capital Management, the,owner, ... outstanding,shares of common stock of VistaCare, Inc. (Nasdaq: ... to VistaCare,s Board of Directors stating,that a review of ...
Cached Medicine News:Health News:Smokers might benefit from earlier colon cancer screening 2Health News:Vendormate and CHCA Finalize Agreement to Offer Compliance and Security Solutions to Children's Hospitals 2Health News:Scientists solve structure of gene regulator that plays key role in cancer 2Health News:Scientists solve structure of gene regulator that plays key role in cancer 3Health News:Quintiles Central Laboratory in India Receives CAP Certification 2Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 2Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 3Health News:Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 4
... and 4 metal chest electrodes on ... procedure enabling a patient to easily ... ECG through a simple change of ... per lead and 10 seconds of ...
... IMPACs comprehensive information system designed specifically ... integrate and streamline their diagnostic, management, ... intuitive software solution. Thousands of laboratory ... have proven PowerPaths unique "case-centric model ...
... The Digital-Photo Adapter ... designed optics for the ... technology. In combination with ... this is the best ...
... The CMGS-1 Color Mini-Ganzfeld Stimulator is ... can be integrated with your existing LKC ... with other visual electrodiagnostic test systems. ... is the smallest commercial Ganzfeld to meet ...
Medicine Products: